Name

oaia2

Label

Oral Anti-Inflammatory Asthma Drugs (Leukotriene Receptor Antagonists And Inhibitors Of Lipo-Oxygenase) (SHHS2)

Description

Participant taking ORAL ANTI-INFLAMMATORY ASTHMA DRUGS (LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE) within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain

noyes01

0: No
1: Yes

Type

choices

	Visit 1	Visit 2	CVD Outcomes
Total	5,804	4,080	5,042
No	-	3,581	-
Yes	-	39	-
Unknown	5,804	460	5,042

	39.0 to 55.0 years	55.0 to 63.0 years	63.0 to 72.0 years	72.0 to 100.0 years	Total
Total	1,451	1,451	1,451	1,451	5,804
No	-	-	-	-	-
Yes	-	-	-	-	-
Unknown	1,451	1,451	1,451	1,451	5,804

	Female	Male	Total
Total	3,039	2,765	5,804
No	-	-	-
Yes	-	-	-
Unknown	3,039	2,765	5,804

	Female	Male	Total
Total	2,219	1,861	4,080
No	1,935	1,646	3,581
Yes	24	15	39
Unknown	260	200	460

	white	black	native amer/alaskan	asian/pacific islander	hispanic/mex. amer	other	Total
Total	4,907	515	11	88	280	3	5,804
No	-	-	-	-	-	-	-
Yes	-	-	-	-	-	-	-
Unknown	4,907	515	11	88	280	3	5,804

	white	black	native amer/alaskan	asian/pacific islander	hispanic/mex. amer	other	Total
Total	3,587	256	8	48	180	1	4,080
No	3,131	237	6	43	163	1	3,581
Yes	31	5	-	-	3	-	39
Unknown	425	14	2	5	14	-	460

Sleep Heart Health Study